ArticleThe Journal of urology2025

Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial.

Pedro F S Freitas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.